GlassScriptPhysician profile
Kerry Rifkin
NPI 1730134644
$2,375.36
in general payments reported to CMS, 2019-2025
30 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $687 · 2020: $719 · 2021: $433 · 2022: $282 · 2023: $128 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $297.19 | 2019-2023 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Bard Peripheral Vascular, INC. | $295.97 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $293.49 | 2019-2021 | |
| Venclose INC. | $157.69 | 2020 | |
| Abbvie INC. | $155.90 | 2021 | |
| Abbott Laboratories | $147.45 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $128.64 | 2019-2021 | |
| Opsens INC. | $105.80 | 2019 | |
| Edwards Lifesciences Corporation | $102.19 | 2025 | Sapien 3 Ultra Resilia |
| Portola Pharmaceuticals, LLC | $80.36 | 2019 | |
| Angiodynamics, INC. | $72.73 | 2019-2022 | |
| Smith+Nephew, INC. | $69.79 | 2019-2020 | |
| Philips North America LLC | $64.54 | 2020 | |
| Medtronic USA, INC. | $44.61 | 2019 | |
| Integra Lifesciences Corporation | $38.46 | 2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $38.01 | 2019-2021 | |
| Tactile Systems Technology INC | $37.33 | 2019 | |
| Amgen INC. | $30.98 | 2019-2020 | |
| Inspire Medical Systems, INC. | $24.33 | 2025 | Inspire |
| Osiris Therapeutics INC. | $23.44 | 2019 | |
| Esperion Therapeutics, INC. | $22.98 | 2020 | |
| Braemar Manufacturing, LLC | $22.76 | 2019 | |
| Misonix INC | $19.50 | 2020 | |
| Arbor Pharmaceuticals, INC. | $17.89 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.07 | 2020 | |
| Medtronic Vascular, INC. | $14.67 | 2020 | |
| Csl Behring | $14.55 | 2019 | |
| Amarin Pharma, INC. | $12.54 | 2019 | |
| Pfizer INC. | $12.38 | 2019 | |
| Kci USA, INC. | $12.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Rifkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.